======= ARPC4 ======= == Gene Information == * **Official Symbol**: ARPC4 * **Official Name**: actin related protein 2/3 complex subunit 4 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10093|10093]] * **UniProt**: [[https://www.uniprot.org/uniprot/P59998|P59998]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ARPC4&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ARPC4|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604226|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Functions as actin-binding component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. Seems to contact the mother actin filament. |ARPC4| |Arp2/3 protein complex| |Arp2/3 complex-mediated actin nucleation| |actin filament polymerization| |actin nucleation| |actin polymerization or depolymerization| |site of double-strand break| |protein binding, bridging| |protein polymerization| |ephrin receptor signaling pathway| |positive regulation of actin filament polymerization| |cell projection| |structural constituent of cytoskeleton| |positive regulation of protein polymerization| |immune response-regulating cell surface receptor signaling pathway involved in phagocytosis| |Fc-gamma receptor signaling pathway involved in phagocytosis| |Fc receptor mediated stimulatory signaling pathway| |Fc-gamma receptor signaling pathway| |regulation of actin filament polymerization| |regulation of actin polymerization or depolymerization| |regulation of actin filament length| |positive regulation of supramolecular fiber organization| |actin filament binding| |positive regulation of cytoskeleton organization| |regulation of protein polymerization| |actin filament organization| |Fc receptor signaling pathway| |positive regulation of protein complex assembly| |regulation of actin filament organization| |phagocytosis| |regulation of actin cytoskeleton organization| |enzyme binding| |regulation of supramolecular fiber organization| |regulation of cellular component size| |regulation of actin filament-based process| |immune response-activating cell surface receptor signaling pathway| |regulation of protein complex assembly| |supramolecular fiber organization| |immune response-regulating cell surface receptor signaling pathway| |actin cytoskeleton organization| |transmembrane receptor protein tyrosine kinase signaling pathway| |regulation of anatomical structure size| |positive regulation of cellular component biogenesis| |regulation of cytoskeleton organization| |immune response-activating signal transduction| |actin filament-based process| |immune response-regulating signaling pathway| |positive regulation of organelle organization| |activation of immune response| |enzyme linked receptor protein signaling pathway| |cellular protein-containing complex assembly| |membrane organization| |positive regulation of immune response| |regulation of cellular component biogenesis| |immune effector process| |cytoskeleton organization| |positive regulation of immune system process| |regulation of immune response| |positive regulation of cellular component organization| |regulation of organelle organization| |protein-containing complex assembly| |regulation of immune system process| |protein-containing complex subunit organization| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.98| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|-2.53| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.36| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.36| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-2.26| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.23| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-2.15| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|-2| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|-1.88| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-1.86| |[[:results:exp169|BH1 1μM R04 exp169]]|-1.85| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|-1.72| ^Gene^Correlation^ |[[:human genes:a:arpc2|ARPC2]]|0.743| |[[:human genes:a:actr2|ACTR2]]|0.724| |[[:human genes:a:actr3|ACTR3]]|0.678| |[[:human genes:c:commd5|COMMD5]]|0.646| |[[:human genes:c:commd3|COMMD3]]|0.588| |[[:human genes:c:ccdc22|CCDC22]]|0.569| |[[:human genes:v:vps29|VPS29]]|0.568| |[[:human genes:c:commd7|COMMD7]]|0.565| |[[:human genes:c:commd10|COMMD10]]|0.534| |[[:human genes:c:commd9|COMMD9]]|0.512| |[[:human genes:c:chka|CHKA]]|0.504| |[[:human genes:k:kiaa0196|KIAA0196]]|0.5| |[[:human genes:c:commd2|COMMD2]]|0.482| |[[:human genes:r:rab7a|RAB7A]]|0.465| |[[:human genes:c:commd4|COMMD4]]|0.459| |[[:human genes:a:acsl4|ACSL4]]|0.459| |[[:human genes:u:usp32|USP32]]|0.453| |[[:human genes:c:ccdc53|CCDC53]]|0.449| |[[:human genes:m:mmd|MMD]]|0.448| |[[:human genes:a:arpc3|ARPC3]]|0.448| |[[:human genes:k:kiaa1033|KIAA1033]]|0.447| |[[:human genes:n:nckap1l|NCKAP1L]]|0.443| |[[:human genes:v:vps45|VPS45]]|0.436| |[[:human genes:v:vkorc1l1|VKORC1L1]]|0.43| |[[:human genes:g:gpr107|GPR107]]|0.429| |[[:human genes:f:flvcr1|FLVCR1]]|0.427| |[[:human genes:m:mtmr9|MTMR9]]|0.419| |[[:human genes:p:pcyt2|PCYT2]]|0.406| Global Fraction of Cell Lines Where Essential: 123/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|9/28| |blood|1/28| |bone|1/26| |breast|2/33| |central nervous system|9/56| |cervix|0/4| |colorectal|4/17| |esophagus|2/13| |fibroblast|0/1| |gastric|1/16| |kidney|7/21| |liver|9/20| |lung|9/75| |lymphocyte|2/16| |ovary|8/26| |pancreas|3/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|4/9| |thyroid|0/2| |upper aerodigestive|4/22| |urinary tract|9/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2076 * **Expression level (log2 read counts)**: 6.62 {{:chemogenomics:nalm6 dist.png?nolink |}}